Top Analysts Recommend 3 Stocks with Significant Upside Potential
Barclays analyst Raimo Lenschow maintains a Buy rating on Braze (BRZE), raising the price target to $39 from $35. The cloud-based customer engagement platform shows a consensus 46.06% upside potential among top analysts.
TD Cowen's Stacy Ku initiates coverage on AVTX with a Buy recommendation. The biopharmaceutical firm focuses on immune and rare genetic disease therapies, drawing unanimous bullish sentiment from covering analysts.